Credit Suisse Ag Keros Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 34,162 shares of KROS stock, worth $1.96 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,162

Previous 26,642 28.23%

Holding current value

$1.96 Million

Previous $1.06 Million 113.5%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$41.26 - $70.48 $310,275 - $530,009	7,520 Added 28.23%	34,162 $2.26 Million
Q4 2023 Feb 08, 2024	BUY	$27.12 - $41.05 $49,982 - $75,655	1,843 Added 7.43%	26,642 $1.06 Million
Q3 2023 Nov 13, 2023	SELL	$31.57 - $43.02 $68,917 - $93,912	-2,183 Reduced 8.09%	24,799 $790,000
Q2 2023 Aug 11, 2023	BUY	$37.26 - $51.01 $287,311 - $393,338	7,711 Added 40.01%	26,982 $1.08 Million
Q1 2023 May 10, 2023	BUY	$41.44 - $59.32 $77,824 - $111,402	1,878 Added 10.8%	19,271 $822,000
Q4 2022 Feb 13, 2023	BUY	$39.45 - $51.77 $293,744 - $385,479	7,446 Added 74.86%	17,393 $835,000
Q3 2022 Nov 10, 2022	SELL	$27.8 - $40.12 $118,650 - $171,232	-4,268 Reduced 30.02%	9,947 $374,000
Q2 2022 Aug 12, 2022	BUY	$26.03 - $67.04 $143,165 - $368,720	5,500 Added 63.11%	14,215 $393,000
Q1 2022 May 16, 2022	BUY	$42.12 - $59.36 $37,739 - $53,186	896 Added 11.46%	8,715 $473,000
Q4 2021 Feb 14, 2022	SELL	$36.95 - $62.89 $20,692 - $35,218	-560 Reduced 6.68%	7,819 $458,000
Q3 2021 Nov 12, 2021	BUY	$29.27 - $43.71 $351 - $524	12 Added 0.14%	8,379 $332,000
Q2 2021 Aug 16, 2021	BUY	$42.4 - $70.11 $88,446 - $146,249	2,086 Added 33.21%	8,367 $356,000
Q1 2021 May 14, 2021	SELL	$54.0 - $75.28 $482,328 - $672,400	-8,932 Reduced 58.71%	6,281 $386,000
Q4 2020 Feb 12, 2021	BUY	$36.0 - $82.74 $547,668 - $1.26 Million	15,213 New	15,213 $1.07 Million

Others Institutions Holding KROS

# of Institutions

174

Shares Held

30.3M

Call Options Held

76.8K

Put Options Held

View Full List

About Keros Therapeutics, Inc.

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.48B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

More about KROS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account